[Preclinical studies of apomorphine hydrochloride].
Ichise
Jouichi
J
Development Department IV, Pharmaceutical Development Division, Takeda Chemical Industries, Ltd.
Yokokawa
Kiyoshi
K
D000818:Animals; D001058:Apomorphine / Q000494:pharmacology*; D015306:Biogenic Monoamines / Q000502:physiology; D001921:Brain / Q000502:physiology; D004298:Dopamine / Q000494:pharmacology; D018491:Dopamine Agonists / Q000494:pharmacology*; D007172:Erectile Dysfunction / Q000188:drug therapy; D006801:Humans; D008297:Male; D010121:Oxytocin / Q000037:antagonists & inhibitors; D010410:Penile Erection / Q000187:drug effects*; D010413:Penis / Q000294:innervation; D051381:Rats
D015306:Biogenic Monoamines; D018491:Dopamine Agonists; D010121:Oxytocin; D001058:Apomorphine; D004298:Dopamine